BACKGROUND & AIMS: Clostridium difficile toxin A causes acute inflammation and fluid secretion in experimental animals and patients with C difficile infection. We previously reported that toxin A increased cyclooxygenase-2/prostaglandin E(2) (PGE(2)) expression and apoptosis in human colonocytes. Here, we assessed the role of secreted PGE(2) in inflammation and enterocyte apoptosis in toxin A enteritis. METHODS: Effects of PGE(2) and PGE(2) blockade on toxin A-induced apoptosis of human colonocytes (NCM460) and of PGE(2) or toxin A on the Fas ligand (FasL) induction were analyzed by flow cytometry and Western blot. Functional activity of elevated FasL on colonocytes was assessed by coculture of colonocytes with Fas bearing Jurkat T cells. The involvement of PGE(2)-dependent Fas/FasL activation in toxin A enteritis was further assessed in either scid or FasL and Fas deficient mice. RESULTS: Inhibition of cyclooxygenase-2 by NS-398 and of PGE(2) using a blocking antibody markedly attenuated apoptosis in colonocytes exposed to toxin A. Enhanced expression and release of FasL followed PGE(2) or toxin A exposure in vivo and in vitro and also was significantly attenuated by treatment with NS-398 and PGE(2) blocking antibody. PGE(2) acting through an EP1 receptor activated nuclear factor-kappaB, which induced transcription of FasL. Toxin A enteritis was accompanied by increased cellular infiltration, fluid secretion, and mucosal damage in control mice, but this response was markedly reduced in both Fas(-/-) and FasL(-/-) mice. CONCLUSIONS: Toxin A enteritis involves release of PGE(2), which activates the Fas/FasL system, causing enterocyte apoptosis and inflammation.
BACKGROUND & AIMS:Clostridium difficile toxin A causes acute inflammation and fluid secretion in experimental animals and patients with C difficile infection. We previously reported that toxin A increased cyclooxygenase-2/prostaglandin E(2) (PGE(2)) expression and apoptosis in human colonocytes. Here, we assessed the role of secreted PGE(2) in inflammation and enterocyte apoptosis in toxin A enteritis. METHODS: Effects of PGE(2) and PGE(2) blockade on toxin A-induced apoptosis of human colonocytes (NCM460) and of PGE(2) or toxin A on the Fas ligand (FasL) induction were analyzed by flow cytometry and Western blot. Functional activity of elevated FasL on colonocytes was assessed by coculture of colonocytes with Fas bearing Jurkat T cells. The involvement of PGE(2)-dependent Fas/FasL activation in toxin A enteritis was further assessed in either scid or FasL and Fas deficient mice. RESULTS: Inhibition of cyclooxygenase-2 by NS-398 and of PGE(2) using a blocking antibody markedly attenuated apoptosis in colonocytes exposed to toxin A. Enhanced expression and release of FasL followed PGE(2) or toxin A exposure in vivo and in vitro and also was significantly attenuated by treatment with NS-398 and PGE(2) blocking antibody. PGE(2) acting through an EP1 receptor activated nuclear factor-kappaB, which induced transcription of FasL. Toxin A enteritis was accompanied by increased cellular infiltration, fluid secretion, and mucosal damage in control mice, but this response was markedly reduced in both Fas(-/-) and FasL(-/-) mice. CONCLUSIONS: Toxin A enteritis involves release of PGE(2), which activates the Fas/FasL system, causing enterocyte apoptosis and inflammation.
Authors: Dae Hong Kim; Jae Sam Hwang; Ik Hwan Lee; Seung Taek Nam; Ji Hong; Peng Zhang; Li Fang Lu; Junguee Lee; Heon Seok; Charalabos Pothoulakis; John Thomas Lamont; Ho Kim Journal: J Biol Chem Date: 2015-12-11 Impact factor: 5.157
Authors: Jin Ku Kang; Jae Sam Hwang; Hyo Jung Nam; Keun Jae Ahn; Heon Seok; Sung-Kuk Kim; Eun Young Yun; Charalabos Pothoulakis; John Thomas Lamont; Ho Kim Journal: Antimicrob Agents Chemother Date: 2011-08-01 Impact factor: 5.191
Authors: Richard Kellermayer; Scot E Dowd; R Alan Harris; Alfred Balasa; Tiffany D Schaible; Randy D Wolcott; Nina Tatevian; Reka Szigeti; Zhijie Li; James Versalovic; C Wayne Smith Journal: FASEB J Date: 2011-01-12 Impact factor: 5.191
Authors: Tressia C Hing; Samantha Ho; David Q Shih; Ryan Ichikawa; Michelle Cheng; Jeremy Chen; Xinhua Chen; Ivy Law; Robert Najarian; Ciaran P Kelly; Richard L Gallo; Stephan R Targan; Charalabos Pothoulakis; Hon Wai Koon Journal: Gut Date: 2012-07-03 Impact factor: 23.059
Authors: E Kokkotou; D O Espinoza; D Torres; I Karagiannides; S Kosteletos; T Savidge; M O'Brien; C Pothoulakis Journal: Gut Date: 2008-09-29 Impact factor: 23.059
Authors: Simon A Hirota; Vadim Iablokov; Sarah E Tulk; L Patrick Schenck; Helen Becker; Jimmie Nguyen; Samir Al Bashir; Tanis C Dingle; Austin Laing; Jianrui Liu; Yan Li; Jeff Bolstad; George L Mulvey; Glen D Armstrong; Wallace K MacNaughton; Daniel A Muruve; Justin A MacDonald; Paul L Beck Journal: Infect Immun Date: 2012-10-08 Impact factor: 3.441